A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases
NCT07782450
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Idiopathic Inflammatory Myositis
Systemic Sclerosis
Interventions
DRUG:
PF-08154225
Sponsor
Pfizer
Collaborators
[object Object]